Anika Therapeutics
(NASDAQ) ANIK
Anika Therapeutics Financials at a Glance
Market Cap
$190.02M
Revenue (TTM)
$112.82M
Net Income (TTM)
$10.88M
EPS (TTM)
$-0.76
P/E Ratio
-18.69
Dividend
$0.00
Beta (Volatility)
0.82 (Low)
Dividend
$0.00
Beta (Volatility)
0.82 (Low)
Price
$14.35
Volume
13,263
Open
$14.20
Price
$14.35
Volume
13,263
Open
$14.20
Previous Close
$14.18
Daily Range
$14.13 - $14.55
52-Week Range
$7.87 - $15.79
Dividend
$0.00
Beta (Volatility)
0.82 (Low)
Price
$14.35
Volume
13,263
Open
$14.20
Previous Close
$14.18
Daily Range
$14.13 - $14.55
52-Week Range
$7.87 - $15.79
ANIK News
3 Biotech Stocks to Buy in May
ANIK: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Anika Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
235
CEO
Cheryl Renee Blanchard, PhD
Website
www.anika.comHeadquarters
Bedford, MA 01730, US
ANIK Financials
Key Financial Metrics (TTM)
Gross Margin
57%
Operating Margin
-10%
Net Income Margin
-10%
Return on Equity
-7%
Return on Capital
-7%
Return on Assets
-6%
Earnings Yield
-5.35%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$190.02M
Shares Outstanding
13.40M
Volume
13.26K
Short Interest
0.00%
Avg. Volume
145.49K
Financials (TTM)
Gross Profit
$63.81M
Operating Income
$11.05M
EBITDA
$1.83M
Operating Cash Flow
$11.19M
Capital Expenditure
$6.83M
Free Cash Flow
$4.36M
Cash & ST Invst.
$57.48M
Total Debt
$24.20M
Anika Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$30.61M
+2473.3%
Gross Profit
$19.18M
-15.0%
Gross Margin
62.65%
N/A
Market Cap
$190.02M
N/A
Market Cap/Employee
$659.80K
N/A
Employees
288
N/A
Net Income
$292.00K
+101.3%
EBITDA
$2.20M
-91.7%
Quarterly Fundamentals
Net Cash
$33.28M
+12.1%
Accounts Receivable
$23.69M
+0.4%
Inventory
$18.79M
-21.1%
Long Term Debt
$24.20M
+0.8%
Short Term Debt
$0.00
-100.0%
Return on Assets
-5.72%
N/A
Return on Invested Capital
-6.56%
N/A
Free Cash Flow
$3.99M
+1350.5%
Operating Cash Flow
$4.64M
+193.1%